SEC Form 4 · accession 0000899243-15-004244
GYRE THERAPEUTICS, INC. · GYRE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen A Hill
Director
Period of report
Aug 28, 2015
Accepted (ET)
Aug 31, 2015 · 3:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001124105
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 28, 2015 | F | 12,146 | $6.72 | D | 15,711 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects a seven-for-one reverse stock split on August 20, 2015 for shares of Catalyst Biosciences, Inc. (formerly, Targacept, Inc.).